# Risk-stratified follow-up: low-risk survivors to primary care with fast re-entry

Source: https://onco.cc/ideas/idea-acc-risk-stratified-follow-up/  
OnCo record `idea-acc-risk-stratified-follow-up` (Idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Not every survivor needs to see an oncologist every six months for years. Sort people by recurrence risk, send low-risk survivors back to their family doctor with a clear plan, and guarantee rapid return if something changes.

## Summary

Hospital-based follow-up for all survivors consumes specialist capacity without evidence of survival benefit for most low-risk patients. Risk-stratified models (as in England's personalised stratified follow-up) move low-risk patients to supported self-management and primary care, with remote surveillance tests and an open re-access route, reserving specialist follow-up for high-risk patients. Randomised evidence shows equivalence for recurrence detection in breast and colorectal cancer.

## Fields

- Kind: Idea
- Last checked: 2026-09-08
- Hypothesis: Risk-stratified follow-up will release at least a quarter of oncology follow-up capacity and will not worsen stage at recurrence or survivor-reported unmet needs.
- Rationale: Recurrences are mostly detected by symptoms between visits, not at scheduled visits; the visits serve reassurance that can be delivered differently.
- Proposed test: A regional implementation with capacity released, stage at recurrence, time from symptom to re-access, and patient-reported outcomes as endpoints.
- Maturity: being-tested-at-scale
- Actor: policy

## Sources

- Bottleneck evidence (Survivorship and late effects are neglected): NCI Office of Cancer Survivorship statistics: https://cancercontrol.cancer.gov/ocs/statistics

## Connected records

- ideas: [Nurse-led follow-up clinics for survivors, freeing oncologists for active treatment](https://onco.cc/ideas/idea-acc-nurse-led-follow-up-clinics/), [Report death from other causes as an outcome of the prostate cancer service, split by deprivation and ethnicity](https://onco.cc/ideas/idea-prostate-other-cause-mortality-as-a-reported-service-outcome/)
- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Prostate cancer](https://onco.cc/cancers/prostate/)
- bottlenecks: [Nobody owns the follow-up once the oncology clinic lets go](https://onco.cc/bottlenecks/rejuv-agenda-nobody-owns-the-follow-up/), [Not enough oncologists, nurses, pathologists, physicists](https://onco.cc/bottlenecks/b-workforce/), [Survivorship and late effects are neglected](https://onco.cc/bottlenecks/b-survivorship/)
- roadmaps: [Recovery and rejuvenation roadmap: cure is not enough → survivorship gets a name → the cohorts that measured the cost → exercise proven as treatment → biological ageing measured and sold → repair, if anyone funds it](https://onco.cc/roadmaps/rejuvenation-roadmap/), [Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards](https://onco.cc/roadmaps/survivorship-roadmap/)

---
JSON: https://onco.cc/api/v1/entities/idea-acc-risk-stratified-follow-up.json